The GeneTitan family of instruments and proven GeneChip Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and ...

The Business Research Company's Lung Cancer Liquid Biopsy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% On All Global Market Reports With Code ONLINE30 – Stay ...

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) ...

Thermo Fisher Scientific (NYSE:TMO) recently made headlines by entering a collaboration with Ethris GmbH to advance mRNA solutions and putting a $4 billion price tag on part of its diagnostics ...

Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people ...

TMO's financials show profitability but lack a clear positive trend, creating ongoing pressure on the stock price and ...

Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports The auction process does not guarantee a sale, the report said, adding that Thermo Fisher may decide to retain the ...